S
Sarah Becker
Researcher at Brigham and Women's Hospital
Publications - 16
Citations - 1355
Sarah Becker is an academic researcher from Brigham and Women's Hospital. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 4, co-authored 11 publications receiving 575 citations. Previous affiliations of Sarah Becker include Harvard University.
Papers
More filters
Journal ArticleDOI
An Integrative Model of Cellular States, Plasticity, and Genetics for Glioblastoma
Cyril Neftel,Julie Laffy,Mariella G. Filbin,Toshiro Hara,Marni E. Shore,Marni E. Shore,Gilbert J. Rahme,Gilbert J. Rahme,Alyssa R. Richman,Alyssa R. Richman,Dana Silverbush,Dana Silverbush,McKenzie Shaw,Christine M. Hebert,Christine M. Hebert,John M. DeWitt,John M. DeWitt,Simon Gritsch,Simon Gritsch,Elizabeth M. Perez,Elizabeth M. Perez,L. Nicolas Gonzalez Castro,Xiaoyang Lan,Xiaoyang Lan,Nicholas Druck,Christopher Rodman,Danielle Dionne,Alexander Kaplan,Mia Bertalan,Julia L. Small,Kristine Pelton,Sarah Becker,Dennis M. Bonal,Quang-Dé Nguyen,Rachel L. Servis,Jeremy M. Fung,Ravindra Mylvaganam,Lisa Mayr,Johannes Gojo,Christine Haberler,René Geyeregger,Thomas Czech,Irene Slavc,Brian V. Nahed,William T. Curry,Bob S. Carter,Hiroaki Wakimoto,Priscilla K. Brastianos,Tracy T. Batchelor,Anat Stemmer-Rachamimov,Maria Martinez-Lage,Matthew P. Frosch,Ivan Stamenkovic,Nicolo Riggi,Esther Rheinbay,Esther Rheinbay,Michelle Monje,Orit Rozenblatt-Rosen,Daniel P. Cahill,Anoop P. Patel,Tony Hunter,Inder M. Verma,Keith L. Ligon,Keith L. Ligon,David N. Louis,Aviv Regev,Aviv Regev,Bradley E. Bernstein,Bradley E. Bernstein,Itay Tirosh,Mario L. Suvà,Mario L. Suvà +71 more
TL;DR: It is found that malignant cells in glioblastoma exist in four main cellular states that recapitulate distinct neural cell types, are influenced by the tumor microenvironment, and exhibit plasticity.
Journal ArticleDOI
Mitogenic and progenitor gene programmes in single pilocytic astrocytoma cells.
Zachary J. Reitman,Brenton R. Paolella,Brenton R. Paolella,Guillaume Bergthold,Kristine Pelton,Sarah Becker,Robert T. Jones,Claire Sinai,Hayley Malkin,Ying Huang,Leslie Grimmet,Zachary T. Herbert,Yu Sun,Jessica Weatherbee,John A. Alberta,John F. Daley,Orit Rozenblatt-Rosen,Alexandra L. Condurat,Alexandra L. Condurat,Alexandra L. Condurat,Kenin Qian,Prasidda Khadka,Rosalind A. Segal,Daphne A. Haas-Kogan,Mariella G. Filbin,Mariella G. Filbin,Mariella G. Filbin,Mario L. Suvà,Mario L. Suvà,Aviv Regev,Aviv Regev,Charles D. Stiles,Mark W. Kieran,Liliana Goumnerova,Keith L. Ligon,Keith L. Ligon,Alex K. Shalek,Alex K. Shalek,Pratiti Bandopadhayay,Pratiti Bandopadhayay,Pratiti Bandopadhayay,Rameen Beroukhim,Rameen Beroukhim +42 more
TL;DR: Single-cell RNA sequencing is used to reveal molecular hallmarks of the disease that might be targeted therapeutically in Pilocytic astrocytoma, indicating that MAPK signaling is restricted to relatively undifferentiated cancer cells in PA.
Journal ArticleDOI
Liquid biopsy detection of genomic alterations in pediatric brain tumors from cell-free DNA in peripheral blood, CSF, and urine.
Mélanie Pagès,Denisse Rotem,Gregory Gydush,Sarah C. Reed,Justin Rhoades,Gavin Ha,Christopher Lo,Mark Fleharty,M Duran,Robert T. Jones,Sarah Becker,Michaela Haller,Claire Sinai,Liliana Goumnerova,Todd R. Golub,J. Christopher Love,Keith L. Ligon,Karen Wright,Viktor A. Adalsteinsson,Rameen Beroukhim,Pratiti Bandopadhayay +20 more
TL;DR: The feasibility of profiling pediatric brain tumors using ctDNA obtained from plasma, cerebrospinal fluid (CSF) and urine, and a pediatric CNS tumor hybrid-capture panel for deep sequencing of specific mutations and fusions is evaluated.
Journal ArticleDOI
Injection Molded Autoclavable, Scalable, Conformable (iMASC) system for aerosol-based protection: a prospective single-arm feasibility study.
James D. Byrne,Adam J Wentworth,Peter R. Chai,Hen-Wei Huang,Sahab Babaee,Canchen Li,Sarah Becker,Caitlynn Tov,Seokkee Min,Giovanni Traverso +9 more
TL;DR: The iMASC system was shown to successfully fit multiple different face sizes and shapes using an OSHA-approved testing method, and these data support further certification testing needed for use in the healthcare setting.
Journal ArticleDOI
PPM1D mutations are oncogenic drivers of de novo diffuse midline glioma formation
Prasidda Khadka,Zachary J. Reitman,Sophie Lu,G Buchan,Gabrielle Gionet,Frank Dubois,Diana Carvalho,Juliann Shih,Shu Zhang,Noah F. Greenwald,Travis I. Zack,Ofer Shapira,Kristine Pelton,Rachel M. Hartley,Heather Bear,Yohanna Georgis,Spandana Jarmale,Randy Melanson,Kevin Bonanno,Kathleen Schoolcraft,Peter Miller,Alexandra Larisa Condurat,Elizabeth Gonzalez,Kenin Qian,Eric Morin,Jaldeep Langhnoja,Leslie E. Lupien,Veronica Rendo,Jeromy J Digiacomo,Dayle K Wang,Kevin L. Zhou,Rushil Kumbhani,Maria E. Guerra Garcia,Claire Sinai,Sarah Becker,Rachel Schneider,Jayne Vogelzang,Karsten Krug,Amy Goodale,Tanaz Abid,Zohra Kalani,Federica Piccioni,Rameen Beroukhim,Nicole Persky,David E. Root,Angel M. Carcaboso,Benjamin L. Ebert,Christine E. Fuller,O. Babur,Mark W. Kieran,Chris Jones,Hasmik Keshishian,Keith L. Ligon,Steven A. Carr,Timothy N. Phoenix,Pratiti Bandopadhayay +55 more
TL;DR: In this paper , the role of PPM1D mutations in de novo gliomagenesis has been systematically explored, and it was shown that truncating mutations in PPM 1D that increase the stability of its phosphatase are clonal driver events in 11% of Diffuse Midline Gliomas (DMGs) and are enriched in primary pontine tumors.